Next Article in Journal
Convenient Synthesis and Antimicrobial Activity of Some Novel Amino Acid Coupled Triazoles
Previous Article in Journal
Two New Pyranoxanthones from Mesua beccariana (Guttiferae)
Article Menu

Export Article

Open AccessReview
Molecules 2010, 15(10), 6743-6758;

Stem Cells for the Treatment of Neurodegenerative Diseases

Department of Orthopaedics, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, #88 Jiefang Road, Hangzhou, 310009, China
Author to whom correspondence should be addressed.
Received: 13 August 2010 / Revised: 6 September 2010 / Accepted: 8 September 2010 / Published: 27 September 2010
Full-Text   |   PDF [116 KB, uploaded 18 June 2014]


Neurodegenerative diseases are characterized by neurodegenerative changes or apoptosis of neurons involved in networks, leading to permanent paralysis and loss of sensation below the site of the injury. Cell replacement therapy has provided the basis for the development of potentially powerful new therapeutic strategies for a broad spectrum of human neurological diseases. In recent years, neurons and glial cells have successfully been generated from stem cells, and extensive efforts by investigators to develop stem cell-based brain transplantation therapies have been carried out. We review here notable previously published experimental and preclinical studies involving stem cell-based cell for neurodegenerative diseases and discuss the future prospects for stem cell therapy of neurological disorders in the clinical setting. Steady and solid progress in stem cell research in both basic and preclinical settings should support the hope for development of stem cell-based cell therapies for neurological diseases. View Full-Text
Keywords: stem cell; neurodegenerative diseases; treatment stem cell; neurodegenerative diseases; treatment
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Wu, Y.-P.; Chen, W.-S.; Teng, C.; Zhang, N. Stem Cells for the Treatment of Neurodegenerative Diseases. Molecules 2010, 15, 6743-6758.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top